Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 791

Urolithin A

Intended Use: For use as an ingredient in powdered (reconstituted) protein shakes, beverages (ready-to-drink protein shakes, non-milk based meal replacement beverages, instant oatmeal, protein and nutrition bars, and yogurts (Greek yogurts, high-protein yogurts, and yogurt drinks) at typical use levels of 250 mg/serving or 500 mg/serving up to a maximum of 500 mg/serving or 1,000 mg/serving.
Basis: Scientific procedures
Notifier: Amazentis SA
Notifier Address: EPFL Innovation Park, Building C
1015 Lausanne
Switzerland
GRAS Notice (releasable information): GRN 791 (in PDF) (2.3 MB)
Date of closure: Dec 20, 2018
FDA's Letter: FDA has no questions (in PDF) (145 KB)
-
-